Health Products

VANC2 and Vancomycin (ONLINE TDM VANCOMYCIN FOR ROCHE/HITACHI CO (2016-05-26)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
All lots
Manufacturer
Roche Diagnostics GMBH
Sandhoferstrasse 116
Mannheim
68305
GERMANY
B. VANCOMYCIN (ONLINE TDM VANCOMYCIN FOR ROCHE/HITAC04642481190
All lots
Manufacturer
Roche Diagnostics GMBH
Sandhoferstrasse 116
Mannheim
68305
GERMANY
A. VANC2 (ONLINE TDM VANCOMYCIN FOR ROCHE/HITACHI CO4491050190

Introduction

Affected products
  1. VANC2 (ONLINE TDM VANCOMYCIN FOR ROCHE/HITACHI CO


  2. VANCOMYCIN (ONLINE TDM VANCOMYCIN FOR ROCHE/HITAC

Reason

A reference standardization of the Roche vancomycin assays was done by the manufacturer against the reference method. It was decided to correct both methods against the reference method. The COBAS INTEGRA assay was corrected by a reagent modification. The instruction for use of the vancomycin assays already show a method comparison against COBAS INTEGRA with the changed formulation which is not yet available on the market. This may lead to the assumption that both methods are comparable and may affect the interpretation of results. Since the COBAS INTEGRA reagent is not yet adapted, results generated with COBAS INTEGRA are still up to 20% higher than with cobas c or modular p systems.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime